
Enhancing clinical efficiency through master protocol trial design
Running separate protocols for multiple investigational products and disease subpopulations slows development and duplicates infrastructure. There is growing interest in accelerating drug development by creating master protocol trial designs that simultaneously evaluate multiple investigational products and various disease subpopulations under a single overarching protocol and infrastructure, eliminating the need for individual trial protocols. This webinar covers how master protocol trial design streamlines development, improves coordination and enhances operational efficiency.
Master protocols, also known as complex clinical trials, offer adaptive design flexibility. This allows researchers to modify the study by eliminating fewer promising treatments or advancing treatments that show better performance to different phases of the study. In this webinar, the featured speakers explore the benefits and challenges of master protocols, as well as strategies for successful implementation and operationalization.
Learn how master protocol trial designs enhance efficiency, collaboration and decision-making in clinical research.
Speakers:

Melanie Owen
MS, Executive Director, HemOnc Portfolio Delivery Lead, PPD clinical research business of Thermo Fisher Scientific

Susie Cain
RAC, Regulatory Affairs Senior Manager, PPD clinical research business of Thermo Fisher Scientific

Song Wang
Sr. Statistical Science Director, PPD clinical research business of Thermo Fisher Scientific
